Skip to main content

Advertisement

Log in

New prognostic model for extranodal natural killer/T cell lymphoma, nasal type

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Extranodal natural killer/T cell lymphoma, nasal type (ENKTL) is an aggressive disease with a poor prognosis, requiring risk stratification in affected patients. We designed a new prognostic model specifically for ENKTL to identify high-risk patients who need more aggressive therapy. We retrospectively reviewed 158 patients who were newly diagnosed with ENKTL. The estimated 5-year overall survival rate was 39.4 %. Independent prognostic factors included total protein (TP) <60 g/L, fasting blood glucose (FBG) >100 mg/dL, and Korean Prognostic Index (KPI) score ≥2. We constructed a new prognostic model by combining these prognostic factors: group 1 (64 cases (41.0 %)), no adverse factors; group 2 (58 cases (37.2 %)), one adverse factor; and group 3 (34 cases (21.8 %)), two or three adverse factors. The 5-year overall survival (OS) rates of these groups were 66.7, 23.0, and 5.9 %, respectively (p < 0.001). Our new prognostic model had a better prognostic value than did the KPI model alone (p < 0.001). Our proposed prognostic model for ENKTL, including the newly identified prognostic indicators, TP and FBG, demonstrated a balanced distribution of patients into different risk groups with better prognostic discrimination compared with the KPI model alone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Jaffe ES, Chan JK, Su IJ, Frizzera G, Mori S, Feller AC, Ho FC (1996) Report of the workshop on nasal and related extranodal angiocentric T/Natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 20(1):103–111

    Article  CAS  PubMed  Google Scholar 

  2. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997. J Clin Oncol 17(12):3835–3849

    CAS  PubMed  Google Scholar 

  3. Wan M, Chow J, Lei K, Chan W (2004) Allelotyping of gastrointestinal nasal-type NK/T-cell lymphoma. Leuk Res 28(4):339–343. doi:10.1016/j.leukres.2003.08.004

    Article  CAS  PubMed  Google Scholar 

  4. Vose JM, Neumann M, Harris ME, Project IT-CL (2008) International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26(25):4124–4130. doi:10.1200/Jco.2008.16.4558

    Article  PubMed  Google Scholar 

  5. Ai WZ, Chang ET, Fish K, Fu K, Weisenburger DD, Keegan TH (2012) Racial patterns of extranodal natural killer/T-cell lymphoma, nasal type, in California: a population-based study. Br J Haematol 156(5):626–632. doi:10.1111/j.1365-2141.2011.08982.x

    Article  CAS  PubMed  Google Scholar 

  6. Guo H-Q, Huang G-L, Guo C-C, Pu X-X, Lin T-Y (2010) Diagnostic and prognostic value of circulating miR-221 for extranodal natural killer/T-cell lymphoma. Dis Markers 29(5):251–258

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Al-Hakeem DA, Fedele S, Carlos R, Porter S (2007) Extranodal NK/T-cell lymphoma, nasal type. Oral Oncol 43(1):4–14

    Article  PubMed  Google Scholar 

  8. Aviles A, Diaz NR, Neri N, Cleto S, Talavera A (2000) Angiocentric nasal T/natural killer cell lymphoma: a single centre study of prognostic factors in 108 patients. Clin Lab Haematol 22(4):215–220. doi:10.1046/j.1365-2257.2000.00307.x

    Article  CAS  PubMed  Google Scholar 

  9. Cheung MM, Chan JK, Lau WH, Ngan RK, Foo WW (2002) Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 54(1):182–190

    Article  PubMed  Google Scholar 

  10. Chim CS, Ma SY, Au WY, Choy C, Lie AK, Liang R, Yau CC, Kwong YL (2004) Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood 103(1):216–221. doi:10.1182/blood-2003-05-1401

    Article  CAS  PubMed  Google Scholar 

  11. Au WY, Weisenburger DD, Intragumtornchai T, Nakamura S, Kim WS, Sng I, Vose J, Armitage JO, Liang R, Pro IPT-CL (2009) Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 113(17):3931–3937. doi:10.1182/blood-2008-10-185256

    Article  CAS  PubMed  Google Scholar 

  12. Kim TM, Park YH, Lee S-Y, Kim J-H, Kim D-W, Im S-A, Kim T-Y, Kim CW, Heo DS, Bang Y-J, Chang K-H, Kim NK (2005) Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)/II(E) extranodal NK/T-cell lymphoma, nasal type. Blood 106(12):3785–3790

    Article  CAS  PubMed  Google Scholar 

  13. Oshimi K, Kawa K, Nakamura S, Suzuki R, Suzumiya J, Yamaguchi M, Kameoka J, Tagawa S, Imamura N, Ohshima K, Kojya S, Iwatsuki K, Tokura Y, Sato E, Sugimori H, Grp N-CTS (2005) NK-cell neoplasms in Japan. Hematology 10(3):237–245. doi:10.1080/10245330400026162

    Article  PubMed  Google Scholar 

  14. Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee JH, Lee DH, Huh J, Oh SY, Kwon H-C, Kim HJ, Lee SI, Kim JH, Park J, Oh SJ, Kim K, Jung C, Park K, Kim WS (2006) Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 24(4):612–618

    Article  PubMed  Google Scholar 

  15. Kim TM, Lee SY, Jeon YK, Ryoo BY, Cho GJ, Hong YS, Kim HJ, Kim SY, Kim CS, Kim S, Kim JS, Sohn SK, Song HH, Lee JL, Kang YK, Yim CY, Lee WS, Yuh YJ, Kim CW, Heo DS, Lymphoma Subcommittee of the Korean Cancer Study G (2008) Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group. Ann Oncol 19(8):1477–1484

    Article  CAS  PubMed  Google Scholar 

  16. Park BB, Ryoo BY, Lee JH, Kwon HC, Yang SH, Kang HJ, Kim HJ, Oh SY, Ko YH, Huh JR, Lee SS, Nam EM, Park KW, Kim JH, Kang JH, Bang SM, Park S, Kim K, Park K, Suh C, Kim WS (2007) Clinical features and treatment outcomes of angioimmunoblastic T-cell lymphoma. Leuk Lymphoma 48(4):716–722. doi:10.1080/10428190601123989

    Article  PubMed  Google Scholar 

  17. Rodriguez J, Conde E, Gutierrez A, Arranz R, Leon A, Marin J, Bendandi M, Albo C, Caballero MD (2007) The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience. Ann Oncol 18(4):652–657. doi:10.1093/annonc/mdl466

    Article  CAS  PubMed  Google Scholar 

  18. Beltran B, Quinones P, Morales D, Cotrina E, Castillo JJ (2011) Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia/lymphoma. Leuk Res 35(3):334–339. doi:10.1016/j.leukres.2010.08.006

    Article  PubMed  Google Scholar 

  19. Huang JJ, Jiang WQ, Lin TY, Huang Y, Xu RH, Huang HQ, Li ZM (2011) Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type. Ann Oncol 22(1):149–155. doi:10.1093/annonc/mdq314

    Article  CAS  PubMed  Google Scholar 

  20. Cai Q, Luo X, Liang Y, Rao H, Fang X, Jiang W, Lin T, Lin T, Huang H (2013) Fasting blood glucose is a novel prognostic indicator for extranodal natural killer/T-cell lymphoma, nasal type. Br J Cancer 108(2):380–386. doi:10.1038/Bjc.2012.566

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Lee J, Park YH, Kim WS, Lee S-S, Ryoo B-Y, Yang SH, Park KW, Kang JH, Park JO, Lee SH, Kim K, Jung CW, Park YS, Im Y-H, Kang WK, Lee MH, Ko YH, Ahn YC, Park K (2005) Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy. Eur J Cancer 41(10):1402–1408

    Article  PubMed  Google Scholar 

  22. Kim TM, Heo DS (2009) Extranodal NK/T-cell lymphoma, nasal type: new staging system and treatment strategies. Cancer Sci 100(12):2242–2248

    Article  CAS  PubMed  Google Scholar 

  23. Luo J, Chen Y-J, Chang L-J (2012) Fasting blood glucose level and prognosis in non-small cell lung cancer (NSCLC) patients. Lung Cancer 76(2):242–247

    Article  PubMed  Google Scholar 

  24. Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-Lopez A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP (1999) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 17(4):1244

    CAS  PubMed  Google Scholar 

  25. Grillo-Lopez AJ, Cheson BD, Horning SJ, Peterson BA, Carter WD, Varns CL, Klippenstein DL, Shen CD (2000) Response criteria for NHL: importance of ‘normal’ lymph node size and correlations with response rates. Ann Oncol 11(4):399–408. doi:10.1023/A:1008332713631

    Article  CAS  PubMed  Google Scholar 

  26. Kim SJ, Kim BS, Choi CW, Choi J, Kim I, Lee YH, Kim JS (2007) Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type. Ann Oncol 18(8):1382–1387

    Article  CAS  PubMed  Google Scholar 

  27. Watanabe T, Kinoshita T, Itoh K, Yoshimura K, Ogura M, Kagami Y, Yamaguchi M, Kurosawa M, Tsukasaki K, Kasai M, Tobinai K, Kaba H, Mukai K, Nakamura S, Ohshima K, Hotta T, Shimoyama M, Jcog LSG (2010) Pretreatment total serum protein is a significant prognostic factor for the outcome of patients with peripheral T/natural killer-cell lymphomas. Leuk Lymphoma 51(5):813–821. doi:10.3109/10428191003721359

    Article  CAS  PubMed  Google Scholar 

  28. Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus a systematic review and meta-analysis. JAMA J Am Med Assoc 300(23):2754–2764

    Article  CAS  Google Scholar 

  29. Richardson LC, Pollack LA (2005) Therapy insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nat Clin Pract Oncol 2(1):48–53. doi:10.1038/Ncponc0062

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Nature Science Foundation of China (81372883 and 81001052), Science and Technology Planning Project of Guangdong Province, China (2011B031800222), Young Talents Project of Sun Yat-sen University Cancer Center (to Cai Qingqing), Young Talents Project of Sun Yat-sen University (to Cai Qingqing), and Natural Science Foundation of Guangdong Province, China (8151008901000043). This research was also partly supported by the NIH through MD Anderson's Cancer Center Support Grant CA016672.

Conflict of interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Qingqing Cai.

Additional information

Qingqing Cai, Xiaolin Luo, and Guanrong Zhang equally contributed to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cai, Q., Luo, X., Zhang, G. et al. New prognostic model for extranodal natural killer/T cell lymphoma, nasal type. Ann Hematol 93, 1541–1549 (2014). https://doi.org/10.1007/s00277-014-2089-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-014-2089-x

Keywords

Navigation